Dr. Guangxiu Dai is Executive Vice President, Head of Discovery & Global Portfolio Management at HUTCHMED. She leads the Company’s drug discovery efforts and oversees global portfolio strategy and management.

Dr. Dai joined HUTCHMED in 2008 and has more than 17 years of experience with the Company in discovery research and operations, portfolio management and intellectual property strategy. Prior to joining HUTCHMED, Dr. Dai worked at biotech companies in the US. She completed her postdoctoral research at Yale University School of Medicine, US.

Dr. Dai holds a Ph.D. in Chemistry from Iowa State University, US.